S. Naus

发表

Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8

Z. Guan, D. Wildeboer, S. Lichtenthaler, 2006, Biological chemistry.

Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity

G. Holländer, H. Ziltener, S. Naus, 2010, PloS one.

Ectodomain Shedding of the Neural Recognition Molecule CHL1 by the Metalloprotease-disintegrin ADAM8 Promotes Neurite Outgrowth and Suppresses Neuronal Cell Death*

M. Schachner, D. Wildeboer, Melanie Richter, 2004, Journal of Biological Chemistry.

PSGL‐1 function in immunity and steady state homeostasis

W. Seo, D. A. Carlow, H. Ziltener, 2009, Immunological reviews.

Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs

J. Merzaban, J. Rivera-Nieves, S. Rosen, 2007, Nature Immunology.

ADAM proteins as therapeutic targets in loosening of total hip replacement implants?

J. Bartsch, S. Naus, 2005, The Journal of rheumatology.

ADAM8/MS2/CD156a

D. Wildeboer, Andrea Rittger, J. Bartsch, 2005 .

implants ? ADAM proteins as therapeutic targets in loosening of total hip replacement

J. Bartsch, S. Naus, 2005 .

The metalloprotease-disintegrin ADAM8 is essential for the development of experimental asthma.

K. McNagny, C. Zaph, H. Ziltener, 2010, American journal of respiratory and critical care medicine.

Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25

F. Rossi, J. Kast, S. Corbel, 2009, The Journal of experimental medicine.

Tumor Necrosis Factor-α (TNF-α) Regulates Shedding of TNF-α Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection

H. Jockusch, D. Wildeboer, Andrea Rittger, 2010, The Journal of Neuroscience.

ADAM8/MS2/CD156, an emerging drug target in the treatment of inflammatory and invasive pathologies.

G. Koller, J. Bartsch, S. Naus, 2009, Current pharmaceutical design.

Metalloproteinase Disintegrins ADAM8 and ADAM19 Are Highly Regulated in Human Primary Brain Tumors and their Expression Levels and Activities Are Associated with Invasiveness

D. Wildeboer, A. Pagenstecher, Q. Sang, 2006, Journal of neuropathology and experimental neurology.

Feasibility and quality development of biomaterials in the pretest studies of the German National Cohort

J. Linseisen, C. Meisinger, U. Nöthlings, 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

PSGL‐1 function in immunity and steady state homeostasis

W. Seo, D. A. Carlow, H. Ziltener, 2009, Immunological reviews.